Mirae Asset Tiger Bio TOP 10 ETF (KRX:364970)

Assets	244.92B
Expense Ratio	0.40%
PE Ratio	39.72
Dividend (ttm)	45.00
Dividend Yield	0.68%
Ex-Dividend Date	Apr 29, 2026
Payout Frequency	Annual
Payout Ratio	26.76%
1-Year Return	-18.57%

Volume	665,958
Open	6,635.00
Previous Close	6,630.00
Day's Range	6,565.00 - 6,695.00
52-Week Low	6,070.00
52-Week High	9,765.00
Beta	0.46
Holdings	10
Inception Date	Oct 6, 2020

About 364970

Formerly known as Mirae Asset Tiger KRX Bio K-New Deal ETF.

• Asset Class: Equity
• Category: Health Care
• Region: Asia Developed
• Stock Exchange: Korea Stock Exchange
• Ticker Symbol: 364970
• Provider: Tiger ETF
• Index Tracked: KRX Bio K-New Deal Index - KRW - Benchmark TR Gross

Performance

364970 had a total return of -18.57% in the past year, including dividends. Since the fund's inception, the average annual return has been -6.71%.

Top Holdings

99.13% of assets

Name	Symbol	Weight
Celltrion, Inc.	068270	25.66%
Samsung Biologics Co.,Ltd.	207940	25.40%
ALTEOGEN Inc.	196170	23.66%
Yuhan Corporation	000100	5.07%
HLB Co., Ltd.	028300	4.20%
Hanmi Pharm. Co., Ltd.	128940	3.82%
SK Biopharmaceuticals Co., Ltd.	326030	3.68%
ABL Bio Inc.	298380	2.81%
Sam Chun Dang Pharm. Co., Ltd	000250	2.67%
Samsung Epis Holdings Co., Ltd.	0126Z0	2.16%

Dividend History

Ex-Dividend	Amount	Pay Date
Apr 29, 2026	45.000 KRW	May 6, 2026
Apr 29, 2025	10.000 KRW	May 7, 2025
Apr 29, 2024	14.000 KRW	May 3, 2024
Apr 27, 2023	15.000 KRW	May 3, 2023
Apr 28, 2022	5.000 KRW	May 3, 2022
Apr 29, 2021	5.000 KRW	May 4, 2021

Data Sources: S&P Global Market Intelligence, Financial Modeling Prep, and more

Historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep. Several fund data points are also provided by Finnhub.

Last checked:

Sep 23, 2026

Data Sources Report a data error